• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Life Science Equipment

Harvard Bioscience Inc

+ Add to Watchlist


4.3300 USD 0.1500 3.35%

As of 20:10:00 ET on 04/17/2014.

Snapshot for Harvard Bioscience Inc (HBIO)

Open: 4.4500 Day's Range: 4.3100 - 4.4600 Volume: 95,851
Previous Close: 4.4800 52wk Range: 3.4352 - 5.1500 1-Yr Rtn: +22.52%

Stock Chart for HBIO

No chart data available.
  • HBIO:US 4.3300
  • 1D
  • 1M
  • 1Y
Interactive HBIO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HBIO

Current P/E Ratio (ttm) 126.8679
Estimated P/E(12/2014) 28.8667
Relative P/E vs. SPX 7.3773
Earnings Per Share (USD) (ttm) 0.0341
Est. EPS (USD) (12/2014) 0.1500
Est. PEG Ratio 2.8867
Market Cap (M USD) 138.34
Shares Outstanding (M) 31.95
30 Day Average Volume 126,023
Price/Book (mrq) 1.2361
Price/Sale (ttm) 1.2508
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/01/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HBIO

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for HBIO

Harvard Bioscience, Inc. develops, manufactures, and markets tools used in drug discovery research and pharmaceutical and biotechnology companies, universities, and government laboratories. The Company's tools include proteomics products that allow researchers to purify and analyze proteins and ADMET screening products that test drug candidates.

Jeffrey A Duchemin "Jeff"President/CEO/COORobert E Gagnon "Rob"CFO/Secretary/Treasurer
Yoav SibonyVP:Global SalesYong SunVP:Strategic Marketing
More Company Profile & Key Executives for HBIO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil